Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia: Some observations

Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia: Some observations

Bibliographic Details
Main Authors:	Mayur Parihar, Neeraj Arora, Deepak Kumar Mishra
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-01-01
Series:	Indian Journal of Pathology and Microbiology
Online Access:	http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2014;volume=57;issue=1;spage=161;epage=162;aulast=Parihar

Similar Items

Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia
by: Pritish K Bhattacharyya
Published: (2013-01-01)

Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia - accelerated phase: A rare case with review of the literature
by: Narender Kumar, et al.
Published: (2013-01-01)

Apoptosis resistance in chronic myelogenous leukemia
by: Fabíola Attié de Castro, et al.
Published: (2005-09-01)

Bosutinib in the management of chronic myelogenous leukemia
by: Keller-von Amsberg G, et al.
Published: (2013-05-01)

A mathematical model of chronic myelogenous leukemia
by: Neiman, B
Published: (2000)

Analysis of telomere length in chronic myelogenous leukemia.
by: Boultwood, J, et al.
Published: (1997)

Analysis or telomere length in chronic myelogenous leukemia
by: Fidler, C, et al.
Published: (1998)

Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia
by: Gopalarethinam Janani, et al.
Published: (2023-09-01)

Green crystals of death in chronic myelogenous leukemia
by: Mohammad Esmaeil Khedmati, et al.
Published: (2022-01-01)

Wnt Signaling Pathway and Chronic Myelogenous Leukemia
by: HOU Yan, et al.
Published: (2019-02-01)

Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
by: Harnicar S, et al.
Published: (2014-08-01)

Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
by: Poonam P Jain, et al.
Published: (2012-01-01)

Chronic myelogenous leukemia: molecular monitoring in clinical practice
by: N. R. Ryabchikova, et al.
Published: (2014-07-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

Chronic myelogenous leukemia: molecular monitoring in clinical practice
by: N. R. Ryabchikova, et al.
Published: (2014-07-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01)

The treatment of pediatric chronic myelogenous leukemia in the imatinib era
by: Jae Wook Lee, et al.
Published: (2011-03-01)

Activation of the hedgehog pathway in chronic myelogeneous leukemia patients
by: Long Bing, et al.
Published: (2011-01-01)

A case of chronic myelogenous leukemia cutis: A rare presentation
by: U S Kanade, et al.
Published: (2011-01-01)

"Transformation of chronic myelogenous leukemia to Multiple Myeloma: A case report "
by: "Ghavamzadeh A, et al.
Published: (2003-05-01)

"Transformation of chronic myelogenous leukemia to Multiple Myeloma: A case report "
by: "Ghavamzadeh A, et al.
Published: (2003-03-01)

The role of Lyn kinase in the development of imatinib resistance in chronic myelogenous leukemia
by: Camillo Porta, et al.
Published: (2011-12-01)

Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia
by: David N. Perdigoto, et al.
Published: (2017-10-01)

Acute appendicitis revealing a diagnosis of chronic myelogenous leukemia
by: Rita Ahmad, et al.
Published: (2021-04-01)

Role of Lysophospholipid Metabolism in Chronic Myelogenous Leukemia Stem Cells
by: Kazuhito Naka
Published: (2021-07-01)

Inflammation Promotes Oxidative and Nitrosative Stress in Chronic Myelogenous Leukemia
by: Dragoslava Đikić, et al.
Published: (2022-02-01)

Management of chronic myelogenous leukemia with COVID-19 and hepatitis B
by: Tian Yu, et al.
Published: (2023-08-01)

Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
by: Mohammad Ali Mashhadi, et al.
Published: (2014-09-01)

Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy
by: Zhenshu Xu, et al.
Published: (2009-03-01)

TREATMENT WITH IMATINIB MESILAT IN CHRONIC MYELOGENOUS LEUKEMIA – OUR EXPERIENCE
by: Mateja Grat, et al.
Published: (2004-12-01)

Chronic myelogenous leukemia in sickle cell/beta 0 -thalassemia
by: Maha M Sallam, et al.
Published: (2011-01-01)

Dynamics and potential impact of the immune response to chronic myelogenous leukemia.
by: Peter S Kim, et al.
Published: (2008-06-01)

Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia
by: Ramachandran Krishna Chandran, et al.
Published: (2019-03-01)

Erythroid blast crisis in chronic myelogenous leukemia: Case report and review of literature
by: Rochelle Nagales Nagamos, et al.
Published: (2016-01-01)

Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma
by: Haitham Hilal Al-Mahrouqi, et al.
Published: (2021-01-01)

A case of double leukemia: chronic myeloid leukemia intolerant to imatinib and chronic lymphocytic leukemia
by: Miriana Rocchi
Published: (2015-10-01)

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.
by: Boultwood, J, et al.
Published: (1999)

Sudden unilateral visual loss as an initial presentation of chronic myelogenous leukemia
by: Len V Hua, et al.
Published: (2010-03-01)

Focal blast crisis in concomitant myelodysplastic syndrome and chronic myelogenous leukemia
by: Leo Reap, DO, et al.
Published: (2020-01-01)

Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after bone marrow transplantation
by: Castro F.A., et al.
Published: (2004-01-01)